These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 19222432)

  • 1. Neuromuscular blocking drugs and their antagonists in patients with organ disease.
    Craig RG; Hunter JM
    Anaesthesia; 2009 Mar; 64 Suppl 1():55-65. PubMed ID: 19222432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo animal studies with sugammadex.
    Booij LH; van Egmond J; Driessen JJ; de Boer HD
    Anaesthesia; 2009 Mar; 64 Suppl 1():38-44. PubMed ID: 19222430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical pharmacology of sugammadex.
    Bom A; Hope F; Rutherford S; Thomson K
    J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular transmission: new concepts and agents.
    de Boer HD
    J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex in clinical practice.
    Mirakhur RK
    Anaesthesia; 2009 Mar; 64 Suppl 1():45-54. PubMed ID: 19222431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclodextrins and the emergence of sugammadex.
    Booij LH
    Anaesthesia; 2009 Mar; 64 Suppl 1():31-7. PubMed ID: 19222429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The undesirable effects of neuromuscular blocking drugs.
    Claudius C; Garvey LH; Viby-Mogensen J
    Anaesthesia; 2009 Mar; 64 Suppl 1():10-21. PubMed ID: 19222427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of neuromuscular block.
    Srivastava A; Hunter JM
    Br J Anaesth; 2009 Jul; 103(1):115-29. PubMed ID: 19468024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of sugammadex.
    Caldwell JE; Miller RD
    Anaesthesia; 2009 Mar; 64 Suppl 1():66-72. PubMed ID: 19222433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex: another milestone in clinical neuromuscular pharmacology.
    Naguib M
    Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sugammadex--a new agent for reversal of neuromuscular blockade].
    Claudius C; Gätke MR
    Ugeskr Laeger; 2009 Mar; 171(13):1091. PubMed ID: 19321086
    [No Abstract]   [Full Text] [Related]  

  • 13. Sugammadex: a novel approach to reversal of neuromuscular blockade.
    Aniskevich S; Leone BJ; Brull SJ
    Expert Rev Neurother; 2011 Feb; 11(2):185-98. PubMed ID: 21306205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex: a novel neuromuscular blocker binding agent.
    Fields AM; Vadivelu N
    Curr Opin Anaesthesiol; 2007 Aug; 20(4):307-10. PubMed ID: 17620836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
    Ploeger BA; Smeets J; Strougo A; Drenth HJ; Ruigt G; Houwing N; Danhof M
    Anesthesiology; 2009 Jan; 110(1):95-105. PubMed ID: 19104176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block.
    Hogg RM; Mirakhur RK
    Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myths and facts in neuromuscular pharmacology. New developments in reversing neuromuscular blockade.
    Fink H; Hollmann MW
    Minerva Anestesiol; 2012 Apr; 78(4):473-82. PubMed ID: 22454044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.